All In Biotech

Drug Trial Radar · NCT04475224

Phase 3 Study of KP-100IT in Subjects With Acute Spinal Cord Injury

A Non-randomized, Multicenter, Confirmatory Study by Intrathecal Administration of KP-100IT in Subjects With Acute Spinal Cord Injury

Last checked: Nov 19, 2026Latest source record: Aug 26, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

25

Planned (sponsor's estimate)

Start

Jul 13, 2020

Primary completion

Dec 31, 2022

Study completion Jun 30, 2023

Sponsor

Lead sponsor
Kringle Pharma, Inc.Industry
Sponsor type
Industry
First posted
Jul 17, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 89 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is non-randomized, multicenter, confirmatory study by intrathecal administration of KP-100IT, code of HGF (Hepatocyte Growth Factor ) formulation for intrathecal injection, in subjects with acute spinal cord injury.

Conditions

  • Acute Spinal Cord Injury

Interventions

  • KP-100ITDrug

    Intrathecal injection of 0.6 mg HGF starting at 72 hours since the injury and repeating weekly 5 times

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of subjects with an improvement of at least two AIS (American Spinal Injury Association) grade, A to C/D, at 24 weeks after administrationTime frame: 24 weeks

Locations

5 sites in 1 country. Site status is shown where the registry gives one.

  • Spinal Injuries Center

    Iizuka, Fukuoka, Japan · Recruiting

  • Hokkaido Spinal Cord Injury Center

    Bibai, Hokkaido, Japan · Recruiting

  • Japanese Red Cross Kobe Hospital

    Kobe, Hyōgo, Japan · Recruiting

  • Aijinkai Rehabilitation Hospital

    Takatsuki, Osaka, Japan · Recruiting

  • Murayama Medical Center

    Musashimurayama, Tokyo, Japan · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.